Directory
Eva Sese Abizanda

Eva Sese Abizanda

Degree: PhD


esese.lleida.ics(ELIMINAR)@gencat.cat

Publications

  • García MJ; Rivero M; Fernández-Clotet A; de Francisco R; Sicilia B; Mesonero F; de Castro ML; Casanova MJ; Bertoletti F; García-Alonso FJ; López-García A; Vicente R; Calvet X; Barreiro-de Acosta M; Ferrer Rosique J; Varela Trastoy P; Nuñez A; Ricart E; Riestra S; Arias García L; Rodríguez M; Arranz L; Pajares R; Mena R; Calafat M; Camo P; Bermejo F; Ponferrada Á; Madrigal RE; Llaó J; Sesé E; Sánchez E; Pineda Mariño JR; González Muñoza C; Carbajo López AY; Julián AB; Villoria Ferrer A; Baston-Rey I; Jara L; Almela P; Codesido L; de la Maza S; Leal C; Caballol B; Pérez-Martínez I; Vinuesa Campo R; Crespo J; Domènech E; Chaparro M; Gisbert JP

    Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.

    JOURNAL OF CROHNS & COLITIS 18 65-74. .

    [doi:10.1093/ecco-jcc/jjad124]

  • Calafat, M; Torres, P; Tosca-Cuquerella, J; Sánchez-Aldehuelo, R; Rivero, M; Iborra, M; González-Vivo, M; Vera, I; de Castro, L; Bujanda, L; Barreiro-de Acosta, M; González-Muñoza, C; Calvet, X; Benítez, JM; Llorente-Barrio, M; Surís, G; Cañete, F; Arias-García, L; Monfort, D; Castaño-García, A; Garcia-Alonso, FJ; Huguet, JM; Marín-Jímenez, I; Lorente, R; Martín-Cardona, A; Ferrer, JA; Camo, P; Gisbert, JP; Pajares, R; Gomollón, F; Castro-Poceiro, J; Morales-Alvarado, J; Llaó, J; Rodríguez, A; Rodríguez, C; Pérez-Galindo, P; Navarro, M; Jiménez-García, N; Carrillo-Palau, M; Blázquez-Gómez, I; Sesé, E; Almela, P; de la Piscina, PR; Taxonera, C; Rodríguez-Lago, I; Cabrinety, L; Vela, M; Mínguez, M; Mesonero, F; García, MJ; Aguas, M; Márquez, L; Porto, MS; Pineda, JR; García-Etxebarría, K; Bertoletti, F; Brunet, E; Mañosa, M; Domènech, E

    Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology 17 -. .

    [doi:10.1177/17562848231221713]

  • Loras, C; Ruiz-Ramirez, P; Romero, J; Andújar, X; Bargallo, J; Bernardos, E; Boscá-Watts, MM; Brugiotti, C; Brunet, E; Busquets, D; Cerrillo, E; Cortina, FJ; Díaz-Milanés, JA; Dueñas, C; Farrés, R; Golda, T; González-Huix, F; Gornals, JB; Guardiola, J; Julià, D; Lira, A; Llaó, J; Mañosa, M; Marin, I; Millán, M; Monfort, D; Moro, D; Mullerat, J; Navarro, M; Roldán, FP; Pijoan, E; Pons, V; Reyes, J; Rufas, M; Sainz, E; Sanchiz, V; Serracant, A; Sese, E; Soto, C; Troya, J; Zaragoza, N; Tebé, C; Paraira, M; Sudrià-Lopez, E; Mayor, V; Fernández-Bañares, F; Esteve, M

    Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial

    Trials 24 -. .

    [doi:10.1186/s13063-023-07447-1]

  • Casas-Deza, D; Lamuela-Calvo, LJ; Gomollon, F; Arbones-Mainar, JM; Caballol, B; Gisbert, JP; Rivero, M; Sanchez-Rodriguez, E; Garcia, LA; Casbas, AG; Merino, O; Marquez, L; Laredo, V; Martin-Arranz, MD; Serrano, PL; Menendez, SR; Gonzalez-Munoza, C; Parga, LD; Moya, MC; Fuentes-Valenzuela, E; Esteve, M; Iborra, M; Gil, MD; Barreiro-De Acosta, M; Lorente-Poyatos, RH; Mancenido, N; Calafat, M; Rodriguez-Lago, I; Capo, JG; Payeras, MA; Alvarado, VJM; Tardillo, C; Bujanda, L; Munoz-Nunez, JF; Nieto, YB; Bermejo, F; Almela, P; Navarro-Llavat, M; Montiel, PM; Gutierrez, CR; Van Domselaar, M; Sese, E; Perez, TM; Ricart, E; Chaparro, M; Garcia, MJ; Lopez-Sanroman, A; Sicilia, B; Orts, B; Lopez-Garcia, A; Martin-Larraz, E; Perez-Calle, JL; de Francisco, R; Garcia-Planella, E; Domenech, E; Garcia-Loper, S

    Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    JOURNAL OF CROHNS & COLITIS 17 83-91. .

    [doi:10.1093/ecco-jcc/jjac108]

  • Gutierrez, A; Zapater, P; Ricart, E; Gonzalez-Vivo, M; Gordillo, J; Olivares, D; Vera, I; Manosa, M; Gisbert, JP; Aguas, M; Sanchez-Rodriguez, E; Bosca-Watts, M; Laredo, V; Camps, B; Marin-Jimenez, I; Zabana, Y; Martin-Arranz, MD; Munoz, R; Navarro, M; Sierra, E; Madero, L; Vela, M; Perez-Calle, JL; Sainz, E; Calvet, X; Arias, L; Morales, V; Bermejo, F; Fernandez-Salazar, L; Van Domselaar, M; De Castro, L; Rodriguez, C; Munoz-Villafranca, C; Lorente, R; Rivero, M; Iglesias, E; Herreros, B; Busquets, D; Riera, J; Martinez-Montiel, MP; Roldon, M; Roncero, O; Hinojosa, E; Sierra, M; Barrio, J; De Francisco, R; Huguet, J; Merino, O; Carpio, D; Ginard, D; Munoz, F; Marta, P; Almela, P; Argueelles-Arias, F; Alcain, G; Luis, B; Mancenido, N; Lucendo, AJ; Varela, P; Rodriguez-Lago, I; Ramos, L; Laura, S; Sese, E; Acosta, MBD; Domenech, E; Frances, R

    Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine 9 -. .

    [doi:10.3389/fmed.2022.823900]

  • Zabana, Y; Marin-Jimenez, I; Rodriguez-Lago, I; Vera, I; Martin-Arranz, MD; Guerra, I; Gisbert, JP; Mesonero, F; Benitez, O; Taxonera, C; Ponferrada-Diaz, A; Piqueras, M; Lucendo, AJ; Caballol, B; Manosa, M; Martinez-Montiel, P; Bosca-Watts, M; Gordillo, J; Bujanda, L; Mancenido, N; Martinez-Perez, T; Lopez, A; Rodriguez-Gutierrez, C; Garcia-Lopez, S; Vega, P; Rivero, M; Melcarne, L; Calvo, M; Iborra, M; de-Acosta, MB; Sicilia, B; Barrio, J; Perez, JL; Busquets, D; Perez-Martinez, I; Navarro-Llavat, M; Hernandez, V; Argueelles-Arias, F; Esteso, FR; Meijide, S; Ramos, L; Gomollon, F; Munoz, F; Suris, G; de Zarate, JO; Huguet, JM; Llao, J; Garcia-Sepulcre, MF; Sierra, M; Dura, M; Estrecha, S; Coronel, AF; Hinojosa, E; Olivan, L; Iglesias, E; Gutierrez, A; Varela, P; Rull, N; Gilabert, P; Hernandez-Camba, A; Brotons, A; Ginard, D; Sese, E; Carpio, D; Aceituno, M; Cabriada, JL; Gonzalez-Lama, Y; Jimenez, L; Chaparro, M; Roman, ALS; Alba, C; Plaza-Santos, R; Mena, R; Tamarit-Sebastian, S; Ricart, E; Calafat, M; Olivares, S; Navarro, P; Bertoletti, F; Alonso-Galan, H; Pajares, R; Olcina, P; Manzano, P; Domenech, E; Esteve, M

    Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

    Journal of Clinical Medicine 11 -. .

    [doi:10.3390/jcm11020421]

  • Casanova, MJ; Chaparro, M; Minguez, M; Ricart, E; Taxonera, C; Garcia-Lopez, S; Guardiola, J; Lopez-San Roman, A; Iglesias, E; Beltran, B; Sicilia, B; Vera, MI; Hinojosa, J; Riestra, S; Domènech E; Calvet, X; Perez-Calle, JL; Martin-Arranz, MD; Aldeguer, X; Rivero, M; Monfort, D; Barrio, J; Esteve, M; Marquez, L; Lorente, R; Garcia-Planella, E; de Castro, L; Bermejo, F; Merino, O; Rodriguez-Perez, A; Martinez-Montiel, P; Van Domselaar, M; Alcain, G; Dominguez-Cajal, M; Muñoz C; Gomollon, F; Fernandez-Salazar, L; Garcia-Sepulcre, MF; Rodriguez-Lago, I; Gutierrez, A; Arguelles-Arias, F; Rodriguez, C; Rodriguez, GE; Bujanda, L; Llao, J; Varela, P; Ramos, L; Huguet, JM; Almela, P; Romero, P; Navarro-Llavat, M; Abad, A; Ramirez-de la Piscina, P; Lucendo, AJ; Sese, E; Madrigal, RE; Charro, M; Garcia-Herola, A; Pajares, R; Khorrami, S; Gisbert, JP

    Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

    Inflammatory Bowel Diseases 26 606-616. .

    [doi:10.1093/ibd/izz192]

  • Bernet Sánchez A; Bellés Bellés A; Aramburu Arnuelos J; Jover Sanz A; Sesé Abizanda E; Vallverdú Vidal M; García González M

    Entamoeba histolytica liver abscess case: could stool PCR avoid it?

    DIAGNOSIS 7 69-73. .

    [doi:10.1515/dx-2019-0006]

  • Sese, E; Xiol, X; Castellote, J; Rodriguez-Farinas, E; Tremosa, G

    Low complement levels and opsonic activity in hepatic hydrothorax - Its relationship with spontaneous bacterial empyema

    J CLIN GASTROENTEROL 36 75-77. .

    [doi:10.1097/00004836-200301000-00020]

  • RENE, JM; Buenestado, J; Sese, E; Minana, JM

    Acute hepatitis induced by valsartan

    MEDICINA CLINICA 117 637-638. .

  • Chaparro M; Acosta D; Rodríguez C; Mesonero F; Vicuña M; Barreiro-de Acosta M; Fernández-Clotet A; Hernández Martínez Á; Arroyo M; Vera I; Ruiz-Cerulla A; Sicilia B; Cabello Tapia MJ; Muñoz Villafranca C; Castro-Poceiro J; Martínez Cadilla J; Sierra-Ausín M; Vázquez Morón JM; Vicente Lidón R; Bermejo F; Royo V; Calafat M; González-Muñoza C; Leo Carnerero E; Manceñido Marcos N; Torrealba L; Alonso-Galán H; Benítez JM; Ber Nieto Y; Diz-Lois Palomares MT; García MJ; Muñoz JF; Armesto González EM; Calvet X; Hernández-Camba A; Madrigal Domínguez RE; Menchén L; Pérez Calle JL; Piqueras M; Dueñas Sadornil C; Botella B; Martínez-Pérez TJ; Ramos L; Rodríguez-Grau MC; San Miguel E; Fernández Forcelledo JL; Fradejas Salazar PM; García-Sepulcre M; Gutiérrez A; Llaó J; Sesé Abizanda E; Boscá-Watts M; Iyo E; Keco-Huerga A; Martínez Bonil C; Peña González E; Pérez-Galindo P; Varela P; Gisbert JP

    Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.

    AMERICAN JOURNAL OF GASTROENTEROLOGY -. .

    [doi:10.14309/ajg.0000000000002145]